We are led by an accomplished team with an exceptional track record of discovering, developing, and commercializing meaningful therapies for patients while creating value for stockholders. Our founding team has deep knowledge and significant experience in cGMP pathway research and development.
Andy Busch, PhD
Chief Scientific Officer
Mark Currie, PhD
Chair of Scientific Advisory Board
Christopher Wright, MD, PhD
Chief Medical Officer
Chief Operating Officer
Peter Hecht, PhD
Chief Executive Officer
Chief Financial Officer
Our Scientific Advisors
The women and men on our advisory boards bring diverse, global perspectives from basic science, clinical practice and industry to help us create better medicines for CNS disorders.
Andrew E. Budson, MD: Chief of Cognitive & Behavioral Neurology and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs Boston Healthcare System, Associate Director and Education Leader of the Boston University Alzheimer’s Disease Research Center, Professor of Neurology at Boston University School of Medicine, and Lecturer in Neurology at Harvard Medical School
Robert C. Malenka, MD, PhD: Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory, and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford University
David H. Salat, PhD: Director, Brain Aging and Dementia (BAnD) Laboratory, Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital; Associate Professor in Radiology at Harvard Medical School; and Director, Neuroimaging Research for Veterans (NeRVe) Center, Veterans Affairs (VA) Boston Healthcare System.
Daniela Salvemini, PhD: Professor of Pharmacology and Physiology and Director of the Henry and Amelia Nasrallah Center for Neuroscience at St. Louis University
Harald H.H.W. Schmidt, MD, PhD, PharmD: Professor of Pharmacology and Chairman of the Department of Pharmacology and Personalized Medicine at Maastricht University
Eric Smith, MD: Professor of Neurology and the Katthy Taylor Chair in Vascular Dementia at the University of Calgary, Calgary Stroke Program
M Brandon Westover, MD, PhD: Physician Investigator in Neurology at Mass General Research Institute, Associate Professor of Neurology at Harvard Medical School, Associate Neurologist in Neurology at Massachusetts General Hospital, and Co-Founder, Beacon Biosignals